Current clinical algorithms for the diagnosis of human lung adenocarcinoma typically require positivity of stains for thyroid transcription factor 1 (TTF-1) and aspartic proteinase Napsin A (NapA), and negativity of stains for either p40 or p63 [24]. This evidence concerns the gene TTF1 and lung adenocarcinoma.